跳至主要内容
临床试验/NL-OMON43495
NL-OMON43495已完成不适用

Markers for neurocognitive impairment in congenitally CMV infected infants: MARVELYS study - MARVELYS study

Academisch Medisch Centrum0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 11(—)

入选标准

  • Positive Polymerase Chain Reaction (PCR) detection of the CMV in urine or blood in neonates younger than 10 days of life and/or positive CMV PCR in dried blood spot (Guthriecard) in children older than 10 days of age
  • Age: birth - three months of age
  • Written informed consent from the parent(s) or guardian(s).

排除标准

  • No signed consent from the parent(s) or guardian(s).
  • MRI contra-indications (e.g. implanted active devices such as pacemakers or medication pumps)

研究者

相似试验

Markers for neurocognitive impairment in... | 临床试验